RNU7-81P

Across TCGA pan-cancer cohorts, RNU7-81P RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated RNU7-81P data layer.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher RNU7-81P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU7-81P expression acts as an unfavorable survival marker, although some lineages such as GBM and BLCA show a favorable association.

SKCM, MESO, and CHOL are the cancer types where RNU7-81P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	DFS	Tertile	III,IV	0.051	0.619	<.001	66	view →
MESO	OS	Tertile	All	0.130	0.557	.019	54	view →
CHOL	DFS	Tertile	All	0.110	0.508	.008	45	view →
KIRC	DFS	Tertile	All	0.476	0.803	.008	36	view →
LGG	OS	Tertile	All	0.538	0.846	<.001	21	view →
ACC	DFS	Tertile	All	0.389	0.694	.005	18	view →
PRAD	OS	Tertile	All	0.970	0.995	.020	18	view →
GBM	DFS	Tertile	All	0.697	0.195	.036	9	view →
BLCA	DFS	Tertile	All	1.000	0.617	.041	3	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

RNU7-81P–SKCM (DFS)

Open the SKCM breakdown →